President-elect Donald J. Trump’s advisers have spent months trying to identify a disease that will help them build their ...

The World Health Organisation (WHO) has issued advice following a surge in hMPV cases in China, with the disease also on the ...

VYD-2311 is under clinical development by Invivyd and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Simaravibart is under clinical development by Contraria Biotech and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of mRNA vaccines introduced a new paradigm in ...

Concerns have emerged over the Human Metapneumovirus (HMPV), following reports of its outbreak in China, Japan, and cases in ...

EU monitoring cases amid soaring infections across China - Cases of the flu-like virus have spiked across northern Chinese ...

Merck & Co.’s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...

A leading health expert from the World Health Organisation has shared vital information about the human metapneumovirus (HMPV ...

Since the beginning of the season, 13 cases of human metapneumovirus (HMPV) have been officially confirmed in Ukraine.This ...

Beijing has reported a surge in cases of the flu-like human metapneumovirus (HMPV) - but how does it compare to the deadly ...

COVID-19 is less deadly than it was in the pandemic’s early days. But the virus is evolving, meaning scientists must track it ...